Application of hepatobiliary-specific MRI contrast agent Gd-EOB-DTPA in preoperative evaluation of hepatobiliary patients
10.3969/j.issn.1001-5256.2015.06.042
- VernacularTitle:钆塞酸二钠在肝胆手术术前评估中的应用
- Author:
Jiayun JIANG
1
;
Xuesong LI
;
Kuansheng MA
Author Information
1. Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
- Publication Type:Research Article
- Keywords:
liver neoplasms；magetic resonance imaging；contrast media;
Gd-EOB-DTPA;
review
- From:
Journal of Clinical Hepatology
2015;31(6):996-
- CountryChina
- Language:Chinese
-
Abstract:
Gd-EOB-DTPA, a newly applicable hepatocyte-specific contrast agent, is excreted through the biliary tract and the kidney, showing the characteristics of nonspecific extracellular contrast agent and hepatocyte-specific contrast agent. It can provide both dynamic and hepatobiliary images and has been rapidly accepted by clinicians for the diagnosis of liver lesions and preoperative evaluation. Gd-EOB-DTPA can fulfill hepatic perfusion imaging, cholangiography, detection and characterization of focal liver lesions, and evaluation of liver function within the same examination in a relatively short time window. A large number of domestic and foreign studies have confirmed that hepatobiliary-specific contrast-enhanced MRI is significantly superior to MRI scan, contrast-enhanced CT, and ultrasound in diagnosing hepatocellular carcinoma, especially small hepatocellular carcinoma. The features of Gd-EOB-DTPA and its current status and prospect of application in the preoperative evaluation of hepatocellular carcinoma are reviewed in this article.
